Pathstone Family Office’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$285K	Hold	5,000	–	–	﹤0.01%	1338
2023 Q2	$306K	Hold	5,000	–	–	﹤0.01%	953
2023 Q1	$314K	Sell	5,000 -5,000	-50%	-$314K	0.01%	892
2022 Q4	$635K	Hold	10,000	–	–	0.01%	990
2022 Q3	$590K	Buy	10,000 +5,000	+100%	+$295K	0.01%	1002
2022 Q2	$289K	Hold	5,000	–	–	0.01%	801
2022 Q1	$310K	Hold	5,000	–	–	0.01%	734
2021 Q4	$356K	Hold	5,000	–	–	0.01%	661
2021 Q3	$374K	Sell	5,000 -500	-9%	-$37.4K	0.01%	606
2021 Q2	$425K	Hold	5,500	–	–	0.01%	529
2021 Q1	$406K	Buy	+5,500	New	+$406K	0.01%	395